“Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says
In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco
NCI To Lose 19% of Workforce Over Six Years, Broder Says
NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion
NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes
Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines
Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines
DCPC To Merge Two Programs, Reorganizes Chemoprevention
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
